Tradestie Institutional Equity Comparison Engine

UNOV vs MRK โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MRK Overall Edge

MRK Captures Institutional Edge (4โ€“0 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Merck & Co., Inc. (MRK) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, UNOV trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus MRK at 16.1x Forward P/E and 35.2% operating margin (+4.7% YoY). In options structure, UNOV sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against MRK sits in CONSOLIDATION (46th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner MRK
UNOV N/M vs MRK 16.1x Fwd P/E
Growth & Margin Winner MRK
Op Margin N/A vs 35.2% ยท YoY N/A vs +4.7%
Momentum & Technical Winner MRK
1Y +9.5% vs +55.5% ยท 52W Pos 84% vs 81%
Options & Structure Winner MRK
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (46th %ile IV)
UNOV Cboe BZX
Innovator U.S. Equity Ultra Buffer ETF - November
Pharmaceutical Preparations
$41.13
-0.95% 1D
Market Cap N/A
1M Return -0.97%
1Y Return +9.53%
Forward P/E N/M
Unified AI Score
58.7 / 100 HOLD
Tech 48.0 Fund 60.0 Flow 50.0 Mom 50.0
MRK NYSE
Merck & Co., Inc.
Pharmaceutical Preparations
$144.46
-2.23% 1D
Market Cap $364.3B
1M Return -1.02%
1Y Return +55.45%
Forward P/E 16.1x
Unified AI Score
56.6 / 100 HOLD
Tech 47.0 Fund 55.0 Flow 67.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: UNOV +9.53% MRK +55.45% Spread: +45.92 pp (MRK Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
UNOV TTM Op. Margin: N/A MRK TTM Op. Margin: 35.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on UNOV vs MRK. Trailing 12-month operating profitability (UNOV N/A vs MRK 35.2%) and valuation multiples (UNOV N/M vs MRK 16.1x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: UNOV (3) vs MRK (7)
Institutional Metric UNOV MRK Criterion Row Winner
Market Capitalization Scale N/A $364.3B Larger Scale MRK
Trailing P/E Ratio Valuation N/M 147.8x Lower Multiple MRK
Forward P/E Ratio Valuation N/M 16.1x Lower Multiple MRK
Revenue Growth (YoY) Growth N/A +4.7% Higher Growth MRK
Operating Margin (TTM) Profitability N/A 35.2% Higher Margin MRK
Net Profit Margin Profitability N/A 3.6% Higher Margin MRK
Return on Equity (ROE) Capital Efficiency N/A 5.1% Higher ROE MRK
52-Week Range Position Momentum 84% ($37โ€“$42) 81% ($91โ€“$157) Stronger Trend UNOV
Beta / 30D Volatility Risk Regime 0.46ฮฒ ยท 11% Vol 0.20ฮฒ ยท 32% Vol Lower Realized Risk UNOV
Unified Institutional Score Composite Signal 58.7 / 100 (HOLD) 56.6 / 100 (HOLD) Higher Composite UNOV

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full UNOV vs MRK Buy Guide
UNOV UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live UNOV Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MRK CONSOLIDATION
58d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 46th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live MRK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither UNOV nor MRK registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.